,i #aagth ,,congress #ast ,session ,h4 ,r4 #ecid ,,in ,,the ,,house ,,of ,,representatives ,september #bh1 #bjba,mr4 ,bucshon 7for himself and ,ms4 ,schrier7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committee on ,ways and ,means1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to require the ,secretary of ,health and ,human ,services to establish a new program which ensures meaningful access to claims data by clinician-led clinical data registries1 and for other purposes4 #a4 ,short title ,this part may be cited as the ,meaningful ,access to ,federal ,health ,plan ,claims ,data ,act of #bjba4 #b4 ,findings ,congress finds as follows3 7#a7 ,clinician-led clinical data registries serve an important role in promoting1 facilitating1 and conducting medical research and improving quality of healthcare by providing timely and actionable feedback to practitioners on their performance in relation to other practitioners and best clinical practices4 7#b7 ,clinician-led clinical data registries are hindered in their ability to promote medical research and quality improvement by their lack of meaningful access to claims data4 7#c7 ,while the ,centers for ,medicare ,medicaid ,services has established programs for providing access to claims data1 those programs fail to provide clinician-led clinical data registries with meaningful access to such data4 7#d7 ,ensuring clinician-led clinical data registries meaningful access to claims data will enable such entities to better track patient outcomes over time1 expand their ability to assess the safety and effectiveness of medical treatments1 and provide them with the information necessary to assess the cost-effectiveness of therapies4 #c4 ,ensuring meaningful access to claims data by clinician-led clinical data registries 7a7 ,ensuring meaningful access to claims data 7#a7 ,establishment of a new program 7#b7 ,establishment of a new program ,the ,secretary shall establish a new program 7separate from any existing data access programs1 including1 without limitation1 the ,centers for ,medicare ,medicaid ,services ,qualified ,entity 7in this section1 referred to as ,,qe7 ,program 7#db ,u4,s4,c4 #aciekk7e71 #aciekk-#b7 7in this section1 referred to as the ,medicare ,data ,sharing for ,performance ,measurement ,program7 and the ,research ,data ,assistance ,center 7in this section1 referred to as the ,res,d,a,c7 process7 under which the ,secretary shall1 at the request of a clinician-led clinical data registry1 provide timely1 broad1 and continuous access to a database of claims data to such clinician-led clinical data registry for purposes of research1 quality of care measurement and reporting to health care providers1 linking such data with clinical data and performing risk-adjusted1 scientifically valid analyses and research to support quality improvement or patient safety1 and other purposes and uses described herein or approved by the ,secretary4 ,access to a database of claims data pursuant to this subsection shall not be more restrictive than access to data provided under the ,,qe ,program or the ,res,d,a,c process4 7#c7 ,streamlined application process 7,a7 ,initial and recertification application ,prior to gaining access to a database of claims data under the program established in subsection 7a71 a clinician-led clinical data registry shall submit to the ,secretary an application demonstrating that it is qualified 7as determined by the ,secretary7 to use claims data4 ,upon the ,secretary's approval of a clinician-led clinical data registry's application described in this subparagraph1 the ,secretary shall provide access to a database of claims data to such clinician-led clinical data registry for a period of at least #e years4 ,after the expiration of the time period described in this subparagraph1 the clinician-led clinical data registry shall reapply to access the database of claims data under the program established in subsection 7a74 7,b7 ,process ,the ,secretary shall establish a streamlined initial application and recertification application process under which the ,secretary shall approve or deny the clinician-led clinical data registry's application described in subparagraph 7#b77;,a7 within #fj calendar days after receiving the application unless the ,secretary demonstrates a compelling reason for needing additional time to complete the process4 ,if the clinician-led clinical data registry's application described in subparagraph 7#b77;,a7 is denied1 the ,secretary shall provide the reason7s7 for denial4 7#d7 ,appeal rights 7,a7 ,opportunity to appeal ,the ,secretary shall develop and maintain a process by which clinician-led clinical data registries may appeal-- 7i7 the ,secretary's decision to deny the clinician-led clinical data registry's application described in subparagraph 7#b77;,a72 and 7ii7 the ,secretary's failure to approve or deny the clinician-led clinical data registry's application described in subparagraph 7#b77;,a7 within a reasonable timeframe established by the ,secretary4 7,b7 ,deadline for decision ,the ,secretary shall render a decision with respect to an appeal filed by a clinician-led clinical data registry pursuant to subparagraph 7,a7 in a timely manner1 not to exceed #fj calendar days after the ,secretary receives the clinician-led clinical data registry's request for an appeal4 ,notice of such decision shall be provided to the clinician-led clinical data registry filing the appeal before the conclusion of such #fj-;day period4 7#e7 ,broad and timely access to data ,the ,secretary shall structure its database of claims data to allow for various data set queries1 including1 but not limited to1 provider-specific claims data1 clinical specialty-specific claims data1 state-specific claims data1 and nationwide claims data4 ,the ,secretary shall promptly make available to a clinician-led clinical data registry access to claims data requested by such clinician-led clinical data registry within a reasonable timeframe1 not to exceed #cj calendar days1 after the ,secretary approves the request from the clinician-led clinical data registry4 7b7 ,permissible uses of claims data ,clinician-led clinical data registries may-- 7#a7 make available to the public reports evaluating the performance of providers of services and suppliers using the claims data provided to such clinician-led clinical data registry under subsection 7a7 in combination with registry data2 7#b7 use claims data received under subsection 7a7 combined with registry data to conduct additional non-public analyses and provide or charge an access fee for such analyses to authorized users for non-public use2 7#c7 provide or charge an access fee for data sets that link claims data received under subsection 7a7 with registry data to authorized users for non-public use2 and 7#d7 provide or charge an access fee for claims data received under subsection 7a7 to authorized users for non-public use4 7c7 ,fees 7#a7 ,claims data provided to clinician-led clinical data registries ,claims data shall be provided to a clinician-led clinical data registry under subsection 7a7 at a reasonable fee based on the cost of providing such data to the clinician-led clinical data registry4 ,such fee shall be based at least in part on the number of patients included in the claims data provided to such clinician-led clinical data registry4 ,any fee collected pursuant to the preceding sentence shall be deposited in the ,centers for ,medicare ,medicaid ,services ,program ,management ,account4 7#b7 ,analyses and data provided to authorized users ,clinician-led clinical data registries may charge a reasonable1 cost-based fee for providing to authorized users claims data1 data sets linking claims data with registry data1 or analyses described in subsection 7b74 7d7 ,protection of information 7#a7 ,privacy1 security1 and disclosure laws ,the ,secretary shall provide access to a database of claims data pursuant to subsection 7a7 in accordance with applicable information1 privacy1 security1 and disclosure laws1 including1 without limitation1 the ,health ,insurance ,portability and ,accountability ,act of #aiif1 ,public ,law #ajd-aia1 as amended by the ,privacy and ,security provisions set forth in ,section #acdjj of the ,health ,information ,technology for ,economic and ,clinical ,health ,act1 ,public ,law #aaa-e1 the regulations promulgated thereunder codified at #de ,,cfr ,parts #afj and #afd1 and subparagraphs 7,a7 through 7,b7 of section #aje7;a77#c7 of the ,medicare ,access and ,,chip ,reauthorization ,act of #bjae 7#db ,u4,s4,c4 #aciekk-#b7;a77#c774 7#b7 ,prohibition on using analyses or data for marketing purposes ,an authorized user shall not use analyses or data provided or sold under paragraphs 7#b7 through 7#d7 of subsection 7b7 for marketing purposes4 7#c7 ,no redisclosure of analyses or data ,an authorized user in receipt of an analysis or datum provided or sold under paragraphs 7#b7 through 7#d7 of subsection 7b7 shall comply with section #aje7;a77#e7 of ,medicare ,access and ,,chip ,reauthorization ,act of #bjae 7#db ,u4,s4,c4 #aciekk-#b7;a77#e774 7#d7 ,opportunity for providers of services and suppliers to review ,prior to a clinician-led clinical data registry using1 providing1 or charging an access fee for claims data1 data sets linking claims data with registry data1 or analyses described in subsection 7b71 to the extent that such data1 data sets1 or analyses would individually identify a provider of services or supplier who is not being provided or sold such data1 data sets1 or analyses1 such clinician-led clinical data registry shall confidentially make available such data1 data sets1 or analyses to such provider of services or supplier and provide such provider of services or supplier with the opportunity to appeal and correct errors4 7e7 ,data use agreement ,a clinician-led clinical data registry and an authorized user shall enter into a data use agreement regarding the use or disclosure of any claims data or data sets that link claims data with registry data that the clinician-led clinical data registry is providing or charging an access fee to the authorized user under paragraphs 7#c7 through 7#d7 of subsection 7b74 ,such agreement shall include the requirements and prohibitions described in section #aje7;a77#d7 of the ,medicare ,access and ,,chip ,reauthorization ,act of #bjae 7#db ,u4,s4,c4 #aciekk-#b7;a77#d774 7f7 ,assessment for a breach 7#a7 ,in general ,in the case of a breach of a data use agreement1 the ,secretary shall impose an assessment on the clinician-led clinical data registry and the authorized user4 7#b7 ,assessment ,the assessment under subsection 7f77#a7 shall be in an amount up to #ajj for each individual entitled to1 or enrolled for1 benefits under part ,a of title ,,xviii of the ,social ,security ,act or enrolled for benefits under part ,b of such title for whom the clinician-led clinical data registry provided data on to the authorized user4 7#c7 ,deposit of amounts collected ,any amounts collected pursuant to this subsection shall be deposited in the ,federal ,supplementary ,medical ,insurance ,trust ,fund under section #ahda of the ,social ,security ,act 7#db ,u4,s4,c4 #aciet74 7g7 ,discovery or admission as evidence ,claims data released to a clinician-led clinical data registry under subsection 7a7 shall not be subject to discovery or admission as evidence in judicial or administrative proceedings without consent of the applicable provider of services or supplier4 #d4 ,report to congress ,not later than #b years after the date of enactment of this ,act1 and annually thereafter1 the ,secretary shall submit to ,congress a report on the extent to which clinician-led clinical data registries are afforded meaningful access to claims data4 #e4 ,definitions ,in this ,act3 7#a7 ,authorized user ,the term authorized user shall have the meaning ascribed to it in section #aje7;a77#i77;,a7 of the ,medicare ,access and ,,chip ,reauthorization ,act of #bjae 7#db ,u4,s4,c4 #aciekk-#b7;a77#i77;,a771 as well as a government agency or other governmental entity1 researchers1 entities that seek data for purposes of complying with regulations or other requirements of the ,federal ,food and ,drug ,administration1 and other entities approved by the ,secretary4 7#b7 ,claims data ,the term claims data shall have the meaning ascribed to the term data in section #aje7;b77#a77;,b7 of the ,medicare ,access and ,,chip ,reauthorization ,act of #bjae 7#db ,u4,s4,c4 #aciekk-#b7;b77#a77;,b774 7#c7 ,clinician-led clinical data registry ,the term clinician-led clinical data registry shall have the meaning ascribed to it in section #djje7;b7 of the #bast ,century ,cures ,act4 7#d7 ,data use agreement ,the term data use agreement means an agreement described in subsection 7e7 of section #c4 7#e7 ,non-public use ,the term non-public use means for the purposes of-- 7,a7 promoting1 facilitating1 and conducting medical research2 assisting providers of services and suppliers to improve patient safety and to develop and participate in quality and patient care improvement activities1 including developing new models of care2 7,b7 assisting clinician-led clinical data registries in developing and reporting quality measures to health care providers quality measures2 7,c7 educating a government agency or other governmental entity2 and 7,d7 supporting clinical trials and other activities necessary to comply with pre- or post-market approval or adverse event reporting requirements or conditions imposed by the ,federal ,food and ,drug ,administration2 and other purposes approved by the ,secretary4 7#f7 ,provider of services ,the term provider of services shall have the meaning ascribed to it in section #ahfa7u7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7u774 7#g7 ,secretary ,the term ,secretary means the ,secretary of ,health and ,humans ,services4 7#h7 ,supplier ,the term supplier shall have the meaning ascribed to it in section #ahfa7;d7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciex7d774 #f4 ,regulations ,the ,secretary shall promulgate not later than #a year after the enactment of this ,act1 final regulations to implement the provisions of the preceding sections of this ,act4 #g4 ,coverage of promising new technologies under the medicare program 7a7 ,non-,exclusion of items and services furnished under access with data collection ,section #ahfb7;a77#a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciey7a77#a77 is amended-- 7#a7 in subparagraph 7,o71 by striking at the end and2 7#b7 in subparagraph 7,p71 by striking the semicolon at the end and inserting 1 and2 and 7#c7 by adding at the end the following new subparagraph3 7,q7 7i7 in the case of items and services for which evidence is promising but not definitive to determine that the items and services are reasonable and necessary for the diagnosis or treatment of illness of injury or to improve the functioning of a malformed body member1 which are not reasonable and necessary for evidence collection to determine that the reasonable and necessary standard in subparagraph 7,a7 is met2 and 7ii7 for purposes of this subparagraph1 evidence collection may include-- 7,i7 evidence of appropriateness1 impact on quality of life1 effectiveness1 safety or other outcomes as determined by the ,secretary2 and 7,,ii7 evidence derived from real world data repositories1 patient registries1 cohort studies1 randomized controlled trials1 or other studies as determined by the ,secretary2 7iii7 the evidence collection described in clause 7ii7 shall be evidence collection approved by the ,secretary acting through the ,administrator of the ,centers for ,medicare ,medicaid ,services in collaboration with the ,director of the ,agency for ,healthcare ,research and ,quality as meeting the priorities of this title as set forth under ,section #aadb2 7iv7 such evidence collection shall be time-limited to a period of no more than #e years1 unless the ,secretary deems that extension is needed to address remaining gaps in evidence2 7v7 such evidence collection shall be accessible1 include outcomes relevant to patients1 and have transparent governance2 and 7vi7 such evidence collection shall be referred to as ,access with ,data ,collection4 4 7b7 ,effective date ,the amendments made by this section shall apply to items and services furnished after ,december #ca1 #bjba4